Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-06-28 Purchase |
2023-06-28 4:01 pm |
Royalty Pharma plc | RPRX | Legorreta Pablo G. CEO, Chairman of the Board 10% Owner |
130,000 | $29.51 | $3,836,768 | 3,758,980 (Indirect Direct) |
View |
| 2023-06-12 Purchase |
2023-06-13 4:01 pm |
Royalty Pharma plc | RPRX | Legorreta Pablo G. CEO, Chairman of the Board 10% Owner |
90,000 | $32.89 | $2,959,848 | 3,628,980 (Indirect Direct) |
View |
| 2023-06-02 Sale |
2023-06-06 5:07 pm |
Royalty Pharma plc | RPRX | Lloyd George W. EVP, Investments & CLO |
192,221 | $33.7 | $6,478,587 | 806,831 (Indirect Direct) |
View |
| 2023-05-24 Purchase |
2023-05-24 6:45 pm |
Royalty Pharma plc | RPRX | Legorreta Pablo G. CEO, Chairman of the Board 10% Owner |
150,000 | $32.25 | $4,837,440 | 3,538,980 (Indirect Direct) |
View |
| 2023-05-22 Sale |
2023-05-22 8:36 pm |
Royalty Pharma plc | RPRX | RIGGS RORY B Director |
1,750,000 | $32.82 | $57,435,000 | 106,949 (Indirect Direct) |
View |
| 2023-05-16 Purchase |
2023-05-17 6:41 pm |
Royalty Pharma plc | RPRX | Legorreta Pablo G. CEO, Chairman of the Board 10% Owner |
230,000 | $33.38 | $7,676,824 | 3,388,980 (Indirect Direct) |
View |
| 2023-03-29 Sale |
2023-03-30 5:53 pm |
Royalty Pharma plc | RPRX | RIGGS RORY B Director |
139,950 | $36.31 | $5,081,111 | 1,556,949 (Indirect Direct) |
View |
| 2023-03-28 Sale |
2023-03-30 5:52 pm |
Royalty Pharma plc | RPRX | Lloyd George W. EVP, Investments & CLO |
112,779 | $37.06 | $4,179,295 | 1,119,052 (Indirect Direct) |
View |
| 2023-02-23 Sale |
2023-02-27 7:14 pm |
Royalty Pharma plc | RPRX | Lloyd George W. EVP, Investments & CLO |
25,000 | $37.27 | $931,658 | 1,231,831 (Indirect Direct) |
View |
| 2023-02-22 Sale |
2023-02-24 6:26 pm |
Royalty Pharma plc | RPRX | Urist Marshall EVP, Research & Investments |
23,333 | $37.3 | $870,239 | 65,687 (Indirect Direct) |
View |
| 2002-12-12 Sale |
2022-12-13 6:20 pm |
Royalty Pharma plc | RPRX | RIGGS RORY B Director |
60,000 | $42.01 | $2,520,623 | 196,899 (Indirect Direct) |
View |
| 2022-12-05 Sale |
2022-12-07 4:30 pm |
Royalty Pharma plc | RPRX | Giuliani Mario Germano Skyeline Management Ltd Avara Management Ltd Director 10% Owner |
84,302 | $43.15 | $3,637,463 | 33,547,592 (Indirect) |
View |
| 2022-12-01 Sale |
2022-12-05 4:44 pm |
Royalty Pharma plc | RPRX | Giuliani Mario Germano MGG Strategic SICAF SIF S.A. - MGG Strategic MGG Strategic SICAF SIF S.A. Skyeline Management Ltd Avara Management Ltd Director 10% Owner |
362,766 | $44.04 | $15,974,737 | 11,406,894 (Indirect) |
View |
| 2022-11-21 Sale |
2022-11-22 5:29 pm |
Royalty Pharma plc | RPRX | Lloyd George W. EVP, Investments & CLO |
40,000 | $43.14 | $1,725,567 | 1,126,831 (Indirect Direct) |
View |
| 2022-11-17 Sale |
2022-11-21 6:12 pm |
Royalty Pharma plc | RPRX | RIGGS RORY B Director |
120,000 | $42.33 | $5,079,924 | 256,899 (Indirect Direct) |
View |
| 2022-11-10 Sale |
2022-11-14 5:13 pm |
Royalty Pharma plc | RPRX | Lloyd George W. EVP, Investments & CLO |
50,000 | $43.85 | $2,192,613 | 1,568,538 (Indirect Direct) |
View |
| 2022-11-08 Sale |
2022-11-10 5:04 pm |
Royalty Pharma plc | RPRX | Coyne Terrance P. EVP & CFO |
24,500 | $43.47 | $1,065,013 | 990,390 (Indirect Direct) |
View |
| 2022-11-02 Sale |
2022-11-04 7:16 pm |
Royalty Pharma plc | RPRX | Coyne Terrance P. EVP & CFO |
5,500 | $43.06 | $236,846 | 1,014,890 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-06-30 Option Award |
2023-06-30 09:15 am |
N/A N/A |
Royalty Pharma plc | RPRX | Fernandez Henry A Director |
1,208 | $31.03 | 96,191 (Direct) |
View |
| 2023-06-30 Option Award |
2023-06-30 09:12 am |
N/A N/A |
Royalty Pharma plc | RPRX | Bassler Bonnie L Director |
1,208 | $31.03 | 43,785 (Direct) |
View |
| 2023-06-23 Option Award |
2023-06-27 4:30 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Giuliani Mario Germano Director 10% Owner |
7,747 | $0 | 33,555,339 (Direct) |
View |
| 2023-06-23 Option Award |
2023-06-26 4:14 pm |
N/A N/A |
Royalty Pharma plc | RPRX | RIGGS RORY B Director |
7,747 | $0 | 114,696 (Direct) |
View |
| 2023-06-23 Option Award |
2023-06-26 4:12 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Norden Gregory Director |
7,747 | $0 | 64,445 (Direct) |
View |
| 2023-06-23 Option Award |
2023-06-26 4:11 pm |
N/A N/A |
Royalty Pharma plc | RPRX | LOVE TED W Director |
7,747 | $0 | 36,941 (Direct) |
View |
| 2023-06-23 Option Award |
2023-06-26 4:09 pm |
N/A N/A |
Royalty Pharma plc | RPRX | HODGSON DAVID C Director |
7,747 | $0 | 16,421 (Direct) |
View |
| 2023-06-23 Option Award |
2023-06-26 4:07 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Fernandez Henry A Director |
7,747 | $0 | 94,983 (Direct) |
View |
| 2023-06-23 Option Award |
2023-06-26 4:05 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Engelbert Catherine M. Director |
7,747 | $0 | 33,211 (Direct) |
View |
| 2023-06-23 Option Award |
2023-06-26 4:04 pm |
N/A N/A |
Royalty Pharma plc | RPRX | DESOUZA ERROL B Director |
7,747 | $0 | 64,445 (Direct) |
View |
| 2023-06-23 Option Award |
2023-06-26 4:02 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Bassler Bonnie L Director |
7,747 | $0 | 42,577 (Direct) |
View |
| 2023-05-12 Gift |
2023-05-15 9:34 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Legorreta Pablo G. CEO, Chairman of the Board 10% Owner |
20,538 | $0 | 1,700,189 (Indirect) |
View |
| 2023-05-09 Conversion |
2023-05-12 6:43 pm |
N/A N/A |
Royalty Pharma plc | RPRX | RIGGS RORY B Director |
330,000 | $0 | 2,211,008 (Direct) |
View |
| 2023-03-31 Option Award |
2023-03-31 4:40 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Fernandez Henry A Director |
1,049 | $35.73 | 87,236 (Direct) |
View |
| 2023-03-31 Option Award |
2023-03-31 4:38 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Bassler Bonnie L Director |
1,049 | $35.73 | 34,830 (Direct) |
View |
| 2023-02-17 Conversion |
2023-02-17 4:59 pm |
N/A N/A |
Royalty Pharma plc | RPRX | RIGGS RORY B Director |
1,650,000 | $0 | 2,080,958 (Direct) |
View |
| 2023-02-17 Conversion |
2023-02-17 4:57 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Urist Marshall EVP, Research & Investments |
77,000 | $0 | 217,614 (Direct) |
View |
Ownership |
2023-02-10 7:48 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Legorreta Pablo G. CEO, Chairman of the Board 10% Owner |
0 | $0 | 5,709,377 (Indirect) |
View |
| 2022-08-12 Ownership |
2023-02-10 7:48 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Legorreta Pablo G. CEO, Chairman of the Board 10% Owner |
150,640 | $0 | 5,709,377 (Indirect) |
View |
| 2022-12-30 Option Award |
2023-01-03 5:11 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Fernandez Henry A Director |
943 | $39.76 | 86,187 (Direct) |
View |
| 2022-12-30 Option Award |
2023-01-03 5:09 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Bassler Bonnie L Director |
943 | $39.76 | 33,781 (Direct) |
View |
| 2022-08-12 Gift |
2022-11-14 5:13 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Lloyd George W. EVP, Investments & CLO |
5,889 | $0 | 1,568,538 (Direct) |
View |
| 2022-09-30 Option Award |
2022-09-30 4:29 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Bassler Bonnie L Director |
913 | $41.06 | 32,838 (Direct) |
View |
| 2022-09-30 Option Award |
2022-09-30 4:25 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Fernandez Henry A Director |
913 | $41.06 | 85,244 (Direct) |
View |